Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes

Overview of attention for article published in Cardiovascular Diabetology, April 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study

Article in Journal of Endocrinological Investigation (February 2024)

Revisión sistemática de la literatura : costo efectividad de intervenciones farmacológicas de los DPP-4i y SGLT-2i para tratamiento de la diabetes tipo 2 en población mayor a 18 años, 2010-2020 aplicada a Colombia

Article (March 2022)

Comparative effectiveness of dapagliflozin vs DPP‐4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world

Article in Diabetes/Metabolism Research and Reviews (June 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.